Clinical trial
The MARS® Albumin Dialysis System in Patients With Fulminant and Subfulminant…
NCT00224705 · Assistance Publique - Hôpitaux de Paris, Other · Completed
Key facts
| NCT number | NCT00224705 |
|---|---|
| Title | The MARS® Albumin Dialysis System in Patients With Fulminant and Subfulminant Hepatic Failure |
| Official title | Efficacy and Safety of the Albumin Dialysis MARS® Therapy in Patients With Fulminant and Subfulminant Hepatic Failure |
| Lead sponsor | Assistance Publique - Hôpitaux de Paris, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hepatitis |
| Intervention type | Device |
| Interventions | Molecular Adsorbent Recirculating System (MARS®) |
| Enrollment | 110 |
| Start date | Aug 1, 2004 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Sep 23, 2005 |
| Last update posted | Feb 17, 2011 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: